Atlas Trials

Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients

Clinical trial NCT04336254 · UNKNOWN

Trial details

NCT number
NCT04336254
Sponsor
Renmin Hospital of Wuhan University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-05-06
Primary completion
2021-11-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.